Myriad Genetics Inc (NASDAQ:MYGN)

12.18
Delayed Data
As of Aug 07
 -0.21 / -1.69%
Today’s Change
9.24
Today|||52-Week Range
47.10
-55.27%
Year-to-Date

Today’s Trading

Previous close12.39
Today’s open12.32
Day’s range12.11 - 12.54
Volume23,430
Average volume (3 months)1,075,165
Market cap$899.9M
Data as of 3:59pm ET, 08/07/2020

Growth & Valuation

Earnings growth (last year)-96.69%
Earnings growth (this year)-111.38%
Earnings growth (next 5 years)-27.41%
Revenue growth (last year)+10.16%
P/E ratioNM
Price/Sales2.48
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
AXDXAccelerate Diagnosti...+0.82+5.54%
LNTHLantheus Holdings In...+0.27+2.07%
VIVOMeridian Bioscience ...-5.00-20.58%
TRILTrillium Therapeutic...+0.86+11.64%
Data as of 5:15pm ET, 08/07/2020

Financials

Next reporting dateAugust 13, 2020
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$851.1M
Annual profit (last year)$4.6M
Net profit margin0.54%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts